714 assets in Colorectal Cancer

Therapeutic assets addressing Colorectal Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Inca33890 Colorectal Cancer	Incyte Corporation	P3	B (57)
Indocyanine Green Colorectal Cancer	Vadim Kuznetsov	P3	B (57)
Ipilimumab Colorectal Cancer	Centre Georges Francois Leclerc	P3	B (57)
Iron Isomaltoside Colorectal Cancer	Zealand University Hospital	P3	B (57)
Panobinostat Colorectal Cancer	Oslo University Hospital	P2	B (57)
rc148 Colorectal Cancer	RemeGen Co., Ltd.	P2/3	B (57)
Ropivacaine Colorectal Cancer	Tri-Service General Hospital	P4	B (57)
trs003 Colorectal Cancer	Zhejiang Teruisi Pharmaceutical Inc.	P3	B (57)
Golytely Colorectal Cancer	Morehouse School of Medicine	P4	B (56)
Lactobacillus Acidophilus Colorectal Cancer	Dharmais National Cancer Center Hospital	P4	B (56)
Lapatinib Colorectal Cancer	Fudan University	P2	B (56)
Metformin Colorectal Cancer	University of Edinburgh	P3	B (56)
Plenvu Colorectal Cancer	Radboud University Medical Center	P4	B (56)
Prednisone Colorectal Cancer	Exelixis	P3	B (56)
Rivoceranib Colorectal Cancer	Yunpeng Liu	P2	B (56)
Sevacizumab Colorectal Cancer	Jiangsu Simcere Pharmaceutical Co., Ltd.	P3	B (56)
TIL Colorectal Cancer	City of Hope Medical Center	P2	B (56)
Trametinib Colorectal Cancer	Xynomic Pharmaceuticals, Inc.	P2	B (56)
Trastuzumab Colorectal Cancer	Fate Therapeutics	P2	B (56)
Avelumab Colorectal Cancer	Mirror Biologics, Inc.	P3	CCC (55)
Cobimetinib Colorectal Cancer	N.N. Petrov National Medical Research Center of Oncology	P3	CCC (55)
Immunoglobulin G4 [221-Proline], Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Sg001 ?4-Chain), Disulfide With Human Monoclonal Sg001 ?-Chain, Dimer Colorectal Cancer	Hebei Medical University Fourth Hospital	P2/3	CCC (55)
Marcaine Colorectal Cancer	Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)	P4	CCC (55)
Montanide Isa 51 Colorectal Cancer	Roswell Park Cancer Institute	P1/2	CCC (55)
Tucatinib Colorectal Cancer	M.D. Anderson Cancer Center	P2	CCC (55)
Alpha Tocopherol Colorectal Cancer	Fudan University	P3	CCC (54)
Amivantamab-Vmjw Colorectal Cancer	Yonsei University	P2	CCC (54)
Axitinib Colorectal Cancer	Abramson Cancer Center at Penn Medicine	P2	CCC (54)
Brucea Javanica Oil Emulsion Colorectal Cancer	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	P4	CCC (54)
Clostridium Butyricum Colorectal Cancer	The Affiliated Hospital of Qingdao University	P4	CCC (54)
Envafolimab Colorectal Cancer	Sun Yat-sen University	P2/3	CCC (54)
Icaritin Colorectal Cancer	Sir Run Run Shaw Hospital	P4	CCC (54)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer Colorectal Cancer	National Cancer Institute (NCI)	P2	CCC (54)
Lorigerlimab Colorectal Cancer	M.D. Anderson Cancer Center	P2	CCC (54)
Melphalan Colorectal Cancer	Delcath Systems Inc.	P3	CCC (54)
Penpulimab Colorectal Cancer	The First Affiliated Hospital with Nanjing Medical University	P2	CCC (54)
Ringer'S Acetate Colorectal Cancer	Joachim Zdolsek	P4	CCC (54)
Rosuvastatin Colorectal Cancer	Hutchmed	P3	CCC (54)
Sodium Thiosulfate Colorectal Cancer	National Cancer Institute (NCI)	P3	CCC (54)
Toripalimab Colorectal Cancer	Dan Feng	P2	CCC (54)
Zanidatamab Colorectal Cancer	Emory University	P2	CCC (54)
Zanzalintinib Colorectal Cancer	Exelixis	P3	CCC (54)
Abiraterone Colorectal Cancer	Exelixis	P3	CCC (53)
Adenovirus 5/F35-Human Guanylyl Cyclase C-Padre Colorectal Cancer	Thomas Jefferson University	P2	CCC (53)
AK105 Colorectal Cancer	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P2	CCC (53)
Anbenitamab Colorectal Cancer	Peking University Cancer Hospital & Institute	P2	CCC (53)
Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate Colorectal Cancer	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	P2	CCC (53)
Avapritinib Colorectal Cancer	M.D. Anderson Cancer Center	P2	CCC (53)
b1962 Colorectal Cancer	Tasly Biopharmaceuticals Co., Ltd.	P2	CCC (53)
Cbx-12 Colorectal Cancer	National Cancer Institute (NCI)	P2	CCC (53)

Showing 101 to 150 of 714 assets

PreviousPage 3 of 15Next